BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 21042764)

  • 1. Growth and differentiation factor-9 promotes adhesive and motile capacity of prostate cancer cells by up-regulating FAK and Paxillin via Smad dependent pathway.
    Bokobza SM; Ye L; Kynaston HG; Jiang WG
    Oncol Rep; 2010 Dec; 24(6):1653-9. PubMed ID: 21042764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GDF-9 promotes the growth of prostate cancer cells by protecting them from apoptosis.
    Bokobza SM; Ye L; Kynaston HG; Jiang WG
    J Cell Physiol; 2010 Nov; 225(2):529-36. PubMed ID: 20458753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the Metastasis Suppressor, N-Myc Downstream Regulated Gene-1, with Novel Di-2-Pyridylketone Thiosemicarbazones: Suppression of Tumor Cell Migration and Cell-Collagen Adhesion by Inhibiting Focal Adhesion Kinase/Paxillin Signaling.
    Wangpu X; Lu J; Xi R; Yue F; Sahni S; Park KC; Menezes S; Huang ML; Zheng M; Kovacevic Z; Richardson DR
    Mol Pharmacol; 2016 May; 89(5):521-40. PubMed ID: 26895766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential Implication of Paxillin in Cancer Establishment Within the Bone Environment.
    Sobkowicz AD; Sanders AJ; Mason MD; Jiang WG
    Anticancer Res; 2017 Aug; 37(8):4255-4268. PubMed ID: 28739717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth and differentiation factor 9 (GDF-9) induces epithelial-mesenchymal transition in prostate cancer cells.
    Bokobza SM; Ye L; Kynaston H; Jiang WG
    Mol Cell Biochem; 2011 Mar; 349(1-2):33-40. PubMed ID: 21116689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous bone morphogenetic protein-7 controls the motility of prostate cancer cells through regulation of bone morphogenetic protein antagonists.
    Ye L; Lewis-Russell JM; Kynaston H; Jiang WG
    J Urol; 2007 Sep; 178(3 Pt 1):1086-91. PubMed ID: 17644136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic upregulation of matriptase-2 reduces the aggressiveness of prostate cancer cells in vitro and in vivo and affects FAK and paxillin localisation.
    Sanders AJ; Parr C; Martin TA; Lane J; Mason MD; Jiang WG
    J Cell Physiol; 2008 Sep; 216(3):780-9. PubMed ID: 18449907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone morphogenetic protein-9 induces apoptosis in prostate cancer cells, the role of prostate apoptosis response-4.
    Ye L; Kynaston H; Jiang WG
    Mol Cancer Res; 2008 Oct; 6(10):1594-606. PubMed ID: 18922975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth differentiation factor-9 expression is inversely correlated with an aggressive behaviour in human bladder cancer cells.
    Du P; Ye L; Li H; Ruge F; Yang Y; Jiang WG
    Int J Mol Med; 2012 Mar; 29(3):428-34. PubMed ID: 22159313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marine natural products-inspired phenylmethylene hydantoins with potent in vitro and in vivo antitumor activities via suppression of Brk and FAK signaling.
    Sallam AA; Mohyeldin MM; Foudah AI; Akl MR; Nazzal S; Meyer SA; Liu YY; El Sayed KA
    Org Biomol Chem; 2014 Jul; 12(28):5295-303. PubMed ID: 24927150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repulsive guidance molecules, novel bone morphogenetic protein co-receptors, are key regulators of the growth and aggressiveness of prostate cancer cells.
    Li J; Ye L; Kynaston HG; Jiang WG
    Int J Oncol; 2012 Feb; 40(2):544-50. PubMed ID: 22076499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of myopodin expression reduces invasion and motility of PC-3 prostate cancer cells.
    De Ganck A; De Corte V; Bruyneel E; Bracke M; Vandekerckhove J; Gettemans J
    Int J Oncol; 2009 May; 34(5):1403-9. PubMed ID: 19360353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanistic insights of epithelial protein lost in neoplasm in prostate cancer metastasis.
    Collins RJ; Morgan LD; Owen S; Ruge F; Jiang WG; Sanders AJ
    Int J Cancer; 2018 Nov; 143(10):2537-2550. PubMed ID: 30098000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth differentiation factor-9 has divergent effects on proliferation and steroidogenesis of bovine granulosa cells.
    Spicer LJ; Aad PY; Allen D; Mazerbourg S; Hsueh AJ
    J Endocrinol; 2006 May; 189(2):329-39. PubMed ID: 16648300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ARF1 regulates adhesion of MDA-MB-231 invasive breast cancer cells through formation of focal adhesions.
    Schlienger S; Ramirez RA; Claing A
    Cell Signal; 2015 Mar; 27(3):403-15. PubMed ID: 25530216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discoidin domain receptor 2 facilitates prostate cancer bone metastasis via regulating parathyroid hormone-related protein.
    Yan Z; Jin S; Wei Z; Huilian H; Zhanhai Y; Yue T; Juan L; Jing L; Libo Y; Xu L
    Biochim Biophys Acta; 2014 Sep; 1842(9):1350-63. PubMed ID: 24787381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repulsive guidance molecule B (RGMB) plays negative roles in breast cancer by coordinating BMP signaling.
    Li J; Ye L; Sanders AJ; Jiang WG
    J Cell Biochem; 2012 Jul; 113(7):2523-31. PubMed ID: 22415859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CEACAM6 promotes tumor angiogenesis and vasculogenic mimicry in gastric cancer via FAK signaling.
    Zang M; Zhang Y; Zhang B; Hu L; Li J; Fan Z; Wang H; Su L; Zhu Z; Li C; Yan C; Gu Q; Liu B; Yan M
    Biochim Biophys Acta; 2015 May; 1852(5):1020-8. PubMed ID: 25703140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of MiR-375-BMPR2 as a Key Factor Downstream of BMP15/GDF9 on the Smad1/5/8 and Smad2/3 Signaling Pathways.
    Liu C; Yuan B; Chen H; Xu M; Sun X; Xu J; Gao Y; Chen C; Jiang H; Zhang J
    Cell Physiol Biochem; 2018; 46(1):213-225. PubMed ID: 29587293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of macrophage inhibitory cytokine-1 induces metastasis of human prostate cancer cells through the FAK-RhoA signaling pathway.
    Senapati S; Rachagani S; Chaudhary K; Johansson SL; Singh RK; Batra SK
    Oncogene; 2010 Mar; 29(9):1293-302. PubMed ID: 19946339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.